Biote Corp (BTMD)
5.52
-0.12
(-2.13%)
USD |
NASDAQ |
May 21, 14:34
Biote Enterprise Value: 194.24M for May 20, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 20, 2024 | 194.24M |
| May 17, 2024 | 197.58M |
| May 16, 2024 | 200.30M |
| May 15, 2024 | 200.00M |
| May 14, 2024 | 203.64M |
| May 13, 2024 | 205.46M |
| May 10, 2024 | 208.79M |
| May 09, 2024 | 212.74M |
| May 08, 2024 | 207.28M |
| May 07, 2024 | 198.18M |
| May 06, 2024 | 242.69M |
| May 03, 2024 | 240.88M |
| May 02, 2024 | 232.55M |
| May 01, 2024 | 227.85M |
| April 30, 2024 | 222.78M |
| April 29, 2024 | 221.69M |
| April 26, 2024 | 223.14M |
| April 25, 2024 | 225.31M |
| April 24, 2024 | 225.67M |
| April 23, 2024 | 224.95M |
| April 22, 2024 | 224.22M |
| April 19, 2024 | 223.86M |
| April 18, 2024 | 220.24M |
| April 17, 2024 | 223.14M |
| April 16, 2024 | 230.02M |
| Date | Value |
|---|---|
| April 15, 2024 | 236.54M |
| April 12, 2024 | 241.25M |
| April 11, 2024 | 240.16M |
| April 10, 2024 | 238.71M |
| April 09, 2024 | 243.06M |
| April 08, 2024 | 237.99M |
| April 05, 2024 | 236.18M |
| April 04, 2024 | 231.47M |
| April 03, 2024 | 236.90M |
| April 02, 2024 | 232.19M |
| April 01, 2024 | 230.38M |
| March 31, 2024 | 220.80M |
| March 28, 2024 | 223.86M |
| March 27, 2024 | 226.36M |
| March 26, 2024 | 227.43M |
| March 25, 2024 | 231.72M |
| March 22, 2024 | 241.72M |
| March 21, 2024 | 240.29M |
| March 20, 2024 | 245.29M |
| March 19, 2024 | 244.57M |
| March 18, 2024 | 254.57M |
| March 15, 2024 | 263.50M |
| March 14, 2024 | 238.50M |
| March 13, 2024 | 234.22M |
| March 12, 2024 | 206.01M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-13.78M
Minimum
Aug 22 2022
263.50M
Maximum
Mar 15 2024
109.48M
Average
108.70M
Median
Mar 31 2023
Enterprise Value Benchmarks
| Teladoc Health Inc | 2.528B |
| American Shared Hospital Services | 31.51M |
| Novo Integrated Sciences Inc | 10.65M |
| Astrana Health Inc | 1.626B |
| Cryo-Cell International Inc | 82.01M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.07M |
| Revenue (Quarterly) | 46.80M |
| Total Expenses (Quarterly) | 36.38M |
| EPS Diluted (Quarterly) | -0.06 |
| Gross Profit Margin (Quarterly) | 71.44% |
| Profit Margin (Quarterly) | -4.42% |
| Earnings Yield | 1.99% |
| Operating Earnings Yield | 18.77% |
| Normalized Earnings Yield | 7.602 |